GlassScriptPhysician profile
Rolando Henriquez
NPI 1144370990
$16,528.99
in general payments reported to CMS, 2019-2025
51 companies · $1,410 in 2025
The $1,410 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,970 · 2020: $2,112 · 2021: $2,903 · 2022: $2,393 · 2023: $2,422 · 2024: $2,320 · 2025: $1,410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,151.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,906.54 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $2,196.01 | 2020-2025 | |
| Amgen INC. | $1,334.77 | 2019-2025 | Evenity, Prolia, Repatha |
| Astrazeneca Pharmaceuticals LP | $1,198.75 | 2019-2025 | Farxiga, Airsupra |
| Lilly USA, LLC | $1,043.05 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Glaxosmithkline, LLC. | $774.84 | 2019-2025 | Trelegy Ellipta, Arexvy, Bexsero |
| Sanofi-Aventis U.S. LLC | $678.58 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $618.67 | 2021-2025 | |
| Pfizer INC. | $582.19 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $494.01 | 2019-2022 | |
| Corcept Therapeutics | $477.79 | 2022-2025 | Korlym |
| Janssen Pharmaceuticals, INC | $436.50 | 2019-2024 | Xarelto |
| Allergan, INC. | $408.40 | 2019-2020 | |
| Amarin Pharma, INC. | $366.22 | 2019-2023 | |
| Abbott Laboratories | $308.97 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rolando Henriquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.